Sort   by:  
 Page size 
UnknownEffects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways.
Not available
S-EPMC7855468 | biostudies-literature
UnknownEvidence that Maackia amurensis seed lectin (MASL) exerts pleiotropic actions on oral squamous cells with potential to inhibit SARS-CoV-2 infection and COVID-19 disease progression.
Not available
S-EPMC8019238 | biostudies-literature
UnknownEvidence that Maackia amurensis seed lectin (MASL) exerts pleiotropic actions on oral squamous cells to inhibit SARS-CoV-2 infection and COVID-19 disease progression.
Not available
S-EPMC7587785 | biostudies-literature
Genomics
Treatment of Oral Squamous Carcinoma Cells (OSCC) with Maackia amurensis seed lectin (MASL)
PRJNA634012 | ENA
Genomicsroot metagenome
Root-associated bacteria from 6150 masl Raw sequence reads
PRJNA285086 | ENA
ProteomicsIntegrated liver-secreted and plasma proteomics approaches identify a predictive model that stratifies MASH in bariatric patients
Background & Aims Obesity is a major risk factor for metabolic associated steatotic liver disease (MASLD) which can progress from metabolic associated steatotic liver (MASL) to metabolic associated steatohepatitis (MASH). There are currently no effective and validated screening tools to stratify obe...
ORGANISM(S): Homo sapiens (Human) 
2025-04-14 | PXD052798 | Pride
Masld Hepatokine Apasha Masl Liver-secreted proteome Metabolic associated steatohepatitis Biomarker Plasma proteomics Mash Nash Nafld 
ProteomicsIntegrated liver-secreted and plasma proteomics approaches identify a predictive model that stratifies MASH in bariatric patients
Background & Aims Obesity is a major risk factor for metabolic associated steatotic liver disease (MASLD) which can progress from metabolic associated steatotic liver (MASL) to metabolic associated steatohepatitis (MASH). There are currently no effective and validated screening tools to stratify obe...
ORGANISM(S): Homo sapiens (Human) 
2025-04-14 | PXD052784 | Pride
Masld Hepatokine Apasha Masl Liver-secreted proteome Metabolic associated steatohepatitis Biomarker Plasma proteomics Mash Nash Nafld 
TranscriptomicsMulti-Modal Comparison of human Hepatic Stellate Cells identifies novel therapeutic targets for Metabolic Dysfunction-Associated Steatotic Liver Disease
Background and aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) progresses from steatosis (Metabolic dysfunction-associated steatotic liver, MASL) to Metabolic dysfunction-associated steatohepatitis (MASH) with fibrosis. Activation of Hepatic Stellate Cells (HSCs) into fibrogen...
ORGANISM(S): Homo sapiens 
2024-11-13 | GSE244832 | GEO
UnknownMaackia amurensis seed lectin structure and sequence comparison with other M. amurensis lectins.
Not available
S-EPMC12059335 | biostudies-literature
UnknownGlucagon promotes increased hepatic mitochondrial oxidation and pyruvate carboxylase flux in humans with fatty liver disease.
Not available
S-EPMC11612994 | biostudies-literature
Sort   by:  
 Page size